Cargando…

Procalcitonin as diagnostic marker of infection in solid tumors patients with fever

In oncologic patients fever is a non-specific clinical marker of different clinical settings. Procalcitonin (PCT) seems to be the most promising infection marker. We aimed to define the potential role of PCT as an earlier diagnostic marker in patients with fever and solid tumor. This retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vincenzi, B., Fioroni, I., Pantano, F., Angeletti, S., Dicuonzo, G., Zoccoli, A., Santini, D., Tonini, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911581/ https://www.ncbi.nlm.nih.gov/pubmed/27312877 http://dx.doi.org/10.1038/srep28090

Ejemplares similares

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
por: Vincenzi, Bruno, et al.
Publicado: (2012)

Procalcitonin and C-Reactive Protein/Procalcitonin Ratio as Markers of Infection in Patients With Solid Tumors
por: Vassallo, Matteo, et al.
Publicado: (2021)

MicroRNAs and Bone Metastasis: A New Challenge
por: Croset, Martine, et al.
Publicado: (2014)

Utility of Procalcitonin as an Early Diagnostic Marker of Bacteremia in Patients with Acute Fever
por: Kim, Myeong Hee, et al.
Publicado: (2011)

Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
por: Russano, Marco, et al.
Publicado: (2020)

Targeting bone metastases starting from the preneoplastic niche: home sweet home
por: Santini, Daniele, et al.
Publicado: (2011)

Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
por: Russano, Marco, et al.
Publicado: (2020)

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
por: Pantano, Francesco, et al.
Publicado: (2020)

Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment
por: Fioramonti, M., et al.
Publicado: (2018)

Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination
por: Angeletti, Silvia, et al.
Publicado: (2015)

The role of procalcitonin in the diagnosis of bacterial infection after major abdominal surgery: Advantage from daily measurement
por: Spoto, Silvia, et al.
Publicado: (2018)

Evaluation of Diagnostic Value of Procalcitonin as a Marker of Neonatal Bacterial Infections
por: Monsef, Alireza, et al.
Publicado: (2012)

Facing SARS-CoV-2 outbreak in immunotherapy era
por: Citarella, Fabrizio, et al.
Publicado: (2020)

Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Vijayan, Ashitha L., et al.
Publicado: (2017)

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
por: Suriano, Francesca, et al.
Publicado: (2013)

Current and Emerging Biomarkers Predicting Bone Metastasis Development
por: Iuliani, Michele, et al.
Publicado: (2020)

Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms
por: Ribelli, Giulia, et al.
Publicado: (2021)

Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation
por: Iuliani, Michele, et al.
Publicado: (2022)

Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma
por: Simonetti, Sonia, et al.
Publicado: (2022)

Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014)

Procalcitonin, a marker of bacterial infection
por: Gendrel, D., et al.
Publicado: (1997)

Cetuximab in small bowel adenocarcinoma: a new friend?
por: Santini, D, et al.
Publicado: (2010)

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
por: Santini, Daniele, et al.
Publicado: (2015)

Diagnostic and Prognostic Role of Procalcitonin in Infections
por: Hatzistilianou, Maria
Publicado: (2010)

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors
por: Fulgenzi, Claudia Angela Maria, et al.
Publicado: (2022)

Procalcitonin as prognostic marker of mortality
por: Zampieri, S, et al.
Publicado: (2013)

Usage of procalcitonin and sCD14-ST as diagnostic markers for postoperative spinal infection
por: Zhu, Xi, et al.
Publicado: (2022)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Can Procalcitonin Be an Accurate Diagnostic Marker for the Classification of Diabetic Foot Ulcers?
por: Jonaidi Jafari, Nematollah, et al.
Publicado: (2014)

Serum procalcitonin as a diagnostic tool of bacteremia
por: Gartzonika, C, et al.
Publicado: (2010)

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
por: Russano, Marco, et al.
Publicado: (2023)

Response of letter to the editor on Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Saikant, R., et al.
Publicado: (2017)

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
por: Iuliani, Michele, et al.
Publicado: (2015)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

A Review of the Value of Procalcitonin as a Marker of Infection
por: Taylor, Richard, et al.
Publicado: (2017)

Procalcitonin as a marker of the systemic inflammatory response to infection
por: Reinhart, K., et al.
Publicado: (2014)

Copeptin, Procalcitonin and Routine Inflammatory Markers–Predictors of Infection after Stroke
por: Fluri, Felix, et al.
Publicado: (2012)

Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis
por: Pantano, Francesco, et al.
Publicado: (2022)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
por: Iuliani, Michele, et al.
Publicado: (2021)

Procalcitonin may not be a differential diagnostic marker for bacterial infection in febrile patients with chronic gouty arthritis
por: Zhang, Jing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jeag4i95u09kb8f9k380bd48i1